Skip to main content
SpringerLink
Log in

Nursing Issues in Prostate Cancer

  • Chapter
  • First Online:
Prostate Cancer: A Comprehensive Perspective

  • 2979 Accesses

Abstract

The nursing role in prostate cancer has evolved rapidly in response to the medical and surgical advancements. Specialist nurses play a key role in the care of men with prostate cancer pre-diagnosis through to terminal care. By being involved at all stages of the disease prostate care, nurses are a valuable resource for these men and their families, providing information, education, advice, support, and nursing care.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 229.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Drudge-Coates L. Prostate cancer and the principles of hormone therapy. Br J Nurs. 2005;14(7):368–75.

    PubMed  Google Scholar 

  2. Tarrant C, Sinfield P, Agarwal S, Baker R. Is seeing a specialist nurse associated with positive experiences of care? The role and value of specialist nurses in prostate cancer care. BMC Health Serv Res. 2008;8:65.

    Article  PubMed  Google Scholar 

  3. Ream E, Quennell A, Fincham L, Faithfull S, Khoo V, Wilson-Barnett J, et al. Supportive care needs of men living with prostate cancer in England: a survey. Br J Cancer. 2008;98(12):1903–9.

    Article  PubMed  CAS  Google Scholar 

  4. Ream E, Wilson-Barnett J, Faithfull S, Fincham L, Khoo V, Richardson A. Working patterns and perceived contribution of prostate cancer clinical nurse specialists: a mixed method investigation. Int J Nurs Stud. 2009;46(10):1345–54.

    Article  PubMed  Google Scholar 

  5. Smith DP, Supramaniam R, King MT, Ward J, Berry M, Armstrong BK. Age, health, and education determine supportive care needs of men younger than 70 years with prostate cancer. J Clin Oncol. 2007;25(18):2560–6.

    Article  PubMed  Google Scholar 

  6. Madsen LT, Craig C, Kuban D. A multidisciplinary prostate cancer clinic for newly diagnosed patients: developing the role of the advanced practice nurse. Clin J Oncol Nurs. 2009;13(3):305–9.

    Article  PubMed  Google Scholar 

  7. Gray M, Sims T. Prostate cancer: prevention and management of localized disease. Nurse Pract. 2006;31(9):14.

    Article  PubMed  Google Scholar 

  8. Boxhall S, Dougherty M. An evaluation of a specialist nursing role for men with prostate cancer. Urol Nurs. 2003;23(2):148–52.

    PubMed  Google Scholar 

  9. Masood J, Forristal H, Cornes R, Vandal MT, Gujral SS. An audit of patient satisfaction with uro-oncology nurse specialists – a questionnaire study. Int J Urol Nurs. 2007;1(2):81–6.

    Article  Google Scholar 

  10. Hawes S, Malcarne V, Ko C, Sadler G, Banthuia R, Sherman S, et al. Identifying problems faced by spouses and partners of patients with prostate cancer. Oncol Nurs Forum. 2006;33(4):807–14.

    Article  PubMed  Google Scholar 

  11. Galbraith ME, Pedro LW, Jaffe AR, Allen TL. Describing health-related outcomes for couples experiencing prostate cancer: differences and similarities. Oncol Nurs Forum. 2008;35(5):794–801.

    Article  PubMed  Google Scholar 

  12. Crowe H, Costello AJ. Prostate cancer: perspectives on quality of life and impact of treatment on patients and their partners. Urol Nurs. 2003;23(4):279–85.

    PubMed  Google Scholar 

  13. Davies N. Prostate cancer… this practice profile is based on NS395. Nurs Stand. 2008; 22(28): 59. Turner B. Diagnosis and treatment of patients with prostate cancer: the nurse’s role. Nurs Stand. 2007; 21(39): 48–56.

    Google Scholar 

  14. Neal DE, Donovan JL, Martin RM, Hamdy FC. Screening for prostate cancer remains controversial. Lancet. 2009;374(9700):1482–3.

    Article  PubMed  Google Scholar 

  15. Wong L. Where are we now with prostate cancer diagnosis? Trends Urol Men’s Health. 2010;1:18–20.

    Article  Google Scholar 

  16. Strief DM. An overview of prostate cancer: diagnosis and treatment. Medsurg Nurs. 2008;17(4):258.

    PubMed  Google Scholar 

  17. Urological Society of Australia and New Zealand. PSA testing policy. 2009. Available from: http://www.usanz.org.au/uploads/29168/ufiles/USANZ_2009_PSA_Testing_Policy_Final1.pdf. Cited 8 Jan 2011.

  18. Briganti A, Blute ML, Eastham JH, et al. Pelvic lymph node dissection in prostate cancer. Eur Urol. 2009;55:1251–65. Eur Urol. 2009 Dec;56(6):e53.

    Article  PubMed  Google Scholar 

  19. The British Association of Urological Surgeons Ltd. Prostate Cancer Screening. 2010. http://www.baus.org.uk/AboutBAUS/publications/prostate-screening.

  20. American Urological Association. Early Detection of Prostate Cancer Policy Statement. 2009. http://www.avanet.org/content/ava-policies/policy-statements/e/early-detection-of-prostate-cancer.cfm.

  21. Mahon SM. Evidence-based practice. Screening for prostate cancer: informing men about their options. Clin J Oncol Nurs. 2005;9(5):625–7.

    Article  PubMed  Google Scholar 

  22. Turner B. Diagnosis and treatment of patients with prostate cancer: the nurse’s role. Nurs Stand. 2007;21(39):48.

    PubMed  Google Scholar 

  23. James N, McPhail G. The success of a nurse-led, one-stop suspected prostate cancer clinic. Cancer Nurs Pract. 2008;7(3):28–32.

    Google Scholar 

  24. Colella KM, DeLuca G. Shared decision making in patients with newly diagnosed prostate cancer: a model for treatment education and support. Urol Nurs. 2004;24(3):187.

    PubMed  Google Scholar 

  25. O’Rourke M. The older adult with prostate cancer. In: Cope DG, Reb AM, editors. Treatment and care of the older adult with prostate cancer. Pittsburgh: Oncology Nursing Society; 2006. p. 225–49.

    Google Scholar 

  26. Hudak JL, McLeod DG, Brassell SA, Gant DA, Shaar S, Hudak RP, et al. The design and implementation of a multidisciplinary prostate cancer clinic. Urol Nurs. 2007;27(6):491–8.

    PubMed  Google Scholar 

  27. Saca-Hazboun H. Advances in prostate cancer treatment. ONS Connect. 2008;23(9):8–12.

    PubMed  Google Scholar 

  28. Lepore SJ, Helgeson VS, Eton DT, Schulz R. Improving quality of life in men with prostate cancer: a randomized controlled trial of group education interventions. Health Psychol. 2003;22(5):443–52.

    Article  PubMed  Google Scholar 

  29. Ross T. Prostate cancer telephone helpline: nursing from a different perspective. Br J Nurs. 2007;16(3):161–5.

    PubMed  Google Scholar 

  30. Scura KW, Budin W, Garfing E. Telephone social support and education for adaptation to prostate cancer: a pilot study. Oncol Nurs Forum. 2004;31(2):335–8.

    Article  PubMed  Google Scholar 

  31. Kunkel EJ, Myers RE, Lartey PL, Oyesanmi O. Communicating effectively with the patient and family about treatment options for prostate cancer. Semin Urol Oncol. 2000;18(3):233–40.

    PubMed  CAS  Google Scholar 

  32. Klotz L, Zhang L, Lam A, Nam R, Mamedov A, Loblaw A. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J Clin Oncol. 2010;28(1):126–31.

    Article  PubMed  Google Scholar 

  33. The National Comprehensive Cancer Network. Prostate cancer early detection guidelines. 2010. Available from: http://www.nccn.org/network/business_insights/%ef%ac%82ash_updates/%ef%ac%82ash_update_information.aspFlashID12. Accessed 8 Jan 2011.

  34. Wallace M. Uncertainty and quality of life of older men who undergo watchful waiting for prostate cancer. Oncol Nurs Forum. 2003;30(2):303–9.

    Article  PubMed  Google Scholar 

  35. Robinson L, Hughes LC, Adler DC, Strumpf N, Grobe SJ, McCorkle R. Describing the work of nursing: the case of postsurgical nursing interventions for men with prostate cancer. Res Nurs Health. 1999;22(4):321–8.

    Article  PubMed  CAS  Google Scholar 

  36. Madsen LT, Ganey-Code E. Assessing and addressing erectile function concerns in patients postprostatectomy. Oncol Nurs Forum. 2006;33(2):209–11.

    Article  PubMed  Google Scholar 

  37. Tarnhuvud M, Wandel C, Willman A. Nursing interventions to improve the health of men with prostate cancer undergoing radiotherapy: a review. Eur J Oncol Nurs. 2007;11(4):328–39.

    Article  PubMed  Google Scholar 

  38. Zeroski D, Abel L, Butler WM, Wallner K, Merrick GS. Factors affecting patient selection for prostate brachytherapy: what nurses should know. Clin J Oncol Nurs. 2005;9(5):553–60.

    Article  PubMed  Google Scholar 

  39. Thompson IM, Tangen CM, Paradelo J, Lucia MS, Miller G, Troyer D, et al. Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial. J Urol. 2009;181(3):956–62.

    Article  PubMed  Google Scholar 

  40. Palmer MH, Fogarty LA, Somerfield MR, Powel LL. Incontinence after prostatectomy: coping with incontinence after prostate cancer surgery. Oncol Nurs Forum. 2003;30(2):229–38.

    Article  PubMed  Google Scholar 

  41. McGlynn B, Al-Saffar N, Begg H, Gurun M, Hollins G, McPhee S, et al. Management of urinary incontinence following radical prostatectomy. Urol Nurs. 2004;24(6):475–82, 515.

    PubMed  Google Scholar 

  42. Moore KN, Estey A. The early post-operative concerns of men after radical prostatectomy. J Adv Nurs. 1999;29(5):1121–9.

    Article  PubMed  CAS  Google Scholar 

  43. Ko WF, Sawatzky JA. Understanding urinary incontinence after radical prostatectomy: a nursing framework. Clin J Oncol Nurs. 2008;12(4):647–54.

    Article  PubMed  Google Scholar 

  44. Talcott JA, Rieker P, Propert KJ, Clark JA, Wishnow KI, Loughlin KR, et al. Patient-reported impotence and incontinence after nerve sparing radical prostatectomy. J Natl Cancer Inst. 1997;89(15):1117–23.

    Article  PubMed  CAS  Google Scholar 

  45. Dorey G. Restoring pelvic floor function in men: review of RCTs. Br J Nurs. 2005;14(19):1014–8, 20–1.

    PubMed  Google Scholar 

  46. Nahon I, Dorey G, Waddington G, Adams R. Systematic review of the treatment of post-prostatectomy incontinence. Urol Nurs. 2006;26(6):461–75. 82.

    PubMed  Google Scholar 

  47. Zhang AY, Strauss GJ, Siminoff LA. Intervention of urinary incontinence and quality of life outcome in prostate cancer patients. J Psychosoc Oncol. 2006;24(2):17–30.

    Article  PubMed  Google Scholar 

  48. Moses K, Wright K, Rutledge D. Managing urinary incontinence following robotic prostatectomy with systematic physical therapy. Oncol Nurs Forum. 2008;35(3):507.

    Google Scholar 

  49. Spickett I, Robertson J. Prostate cancer: the ongoing challenge. Prim Health Care. 2010;20(2):16–21.

    Google Scholar 

  50. Burnett AL, Aus G, Canby-Hagino ED, Cookson MS, D’Amico AV, Dmochowski RR, et al. Erectile function outcome reporting after clinically localized prostate cancer treatment. J Urol. 2007;178(2):597–601.

    Article  PubMed  Google Scholar 

  51. Mulhall JP. Defining and reporting erectile function outcomes after radical prostatectomy: challenges and misconceptions. J Urol. 2009;181(2):462–71.

    Article  PubMed  Google Scholar 

  52. Burnett AL. Erectile dysfunction following radical prostatectomy. JAMA. 2005;293(21):2648–53.

    Article  PubMed  CAS  Google Scholar 

  53. Kendirci M, Bejma J, Hellstrom WJ. Update on erectile dysfunction in prostate cancer patients. Curr Opin Urol. 2006;16(3):186–95.

    Article  PubMed  Google Scholar 

  54. Howlett K, Koetters T, Edrington J, West C, Paul S, Lee K, et al. Changes in sexual function on mood and quality of life in patients undergoing radiation therapy for prostate cancer. Oncol Nurs Forum. 2010;37(1):E58–66.

    Article  PubMed  Google Scholar 

  55. Montorsi F, Guazzoni G, Strambi LF, Da Pozzo LF, Nava L, Barbieri L, et al. Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: results of a prospective, randomized trial. J Urol. 1997;158(4):1408–10.

    Article  PubMed  CAS  Google Scholar 

  56. Bannowsky A, Schulze H, van der Horst C, Hautmann S, Junemann KP. Recovery of erectile function after nerve-sparing radical prostatectomy: improvement with nightly low-dose sildenafil. BJU Int. 2008;101(10):1279–83.

    Article  PubMed  CAS  Google Scholar 

  57. Mulhall JP, Parker M, Waters BW, Flanigan R. The timing of penile rehabilitation after bilateral nerve-sparing radical prostatectomy affects the recovery of erectile function. BJU Int. 2010;105(1):37–41.

    Article  PubMed  Google Scholar 

  58. Montorsi F, Briganti A, Salonia A, Rigatti P, Burnett AL. Current and future strategies for preventing and managing erectile dysfunction following radical prostatectomy. Eur Urol. 2004;45(2):123–33.

    Article  PubMed  Google Scholar 

  59. Pace G, Del Rosso A, Vicentini C. Penile rehabilitation therapy following radical prostatectomy. Disabil Rehabil. 2010;32(14):1204–8.

    Article  PubMed  Google Scholar 

  60. Peltier A, van Velthoven R, Roumeguere T. Current management of erectile dysfunction after cancer treatment. Curr Opin Oncol. 2009;21(4):303–9.

    Article  PubMed  CAS  Google Scholar 

  61. Annon J. Behavioral Treatment of Sexual Problems: Harper & Row – Medical Department; New York: 1976;2.

    Google Scholar 

  62. Gallagher E, Gapstur R. Hormone-refractory prostate cancer: a shifting paradigm in treatment. Clin J Oncol Nurs. 2006;10(2):233–40.

    Article  PubMed  Google Scholar 

  63. Matthews PA. Hormone ablation therapy: lightening the load for today’s prostate cancer patient. Urol Nurs. 2007;27(Suppl):3–11.

    PubMed  Google Scholar 

  64. Sakai H, Igawa T, Tsurusaki T, Yura M, Kusaba Y, Hayashi M, et al. Hot flashes during androgen deprivation therapy with luteinizing hormone-releasing hormone agonist combined with steroidal or nonsteroidal antiandrogen for prostate cancer. Urology. 2009;73(3):635–40.

    Article  PubMed  Google Scholar 

  65. Levine GN, D’Amico AV, Berger P, Clark PE, Eckel RH, Keating NL, et al. Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology. CA Cancer J Clin. 2010;60(3):194–201.

    Article  PubMed  Google Scholar 

  66. Shroder FH, Collette L, De Reijke TM. Prostate cancer treated by anti-androgens: is sexual function preserved? Br J Cancer. 2000;82:283–90.

    Article  Google Scholar 

  67. Weingard KK. Nursing implications of androgen deprivation therapy-associated bone loss. Urol Nurs. 2006;26(4):261–9. quiz 70.

    PubMed  Google Scholar 

  68. Galvao DA, Taaffe DR, Spry N, Joseph D, Turner D, Newton RU. Reduced muscle strength and functional performance in men with prostate cancer undergoing androgen suppression: a comprehensive cross-sectional investigation. Prostate Cancer Prostatic Dis. 2009;12(2):198–203.

    Article  PubMed  CAS  Google Scholar 

  69. Galvao DA, Taaffe DR, Spry N, Newton RU. Exercise can prevent and even reverse adverse effects of androgen suppression treatment in men with prostate cancer. Prostate Cancer Prostatic Dis. 2007;10(4):340–6.

    Article  PubMed  CAS  Google Scholar 

  70. Drudge-Coates L. Bone health: the effect of androgen deprivation therapy in prostate cancer patients. Int J Urol Nurs. 2007;1(1):18–26.

    Article  Google Scholar 

  71. Doggrell S. Clinical efficacy and safety of zoledronic acid in prostate and breast cancer. Expert Rev Anticancer Ther. 2009;9(9):1211–8.

    Article  PubMed  CAS  Google Scholar 

  72. Osborne S. Prostate cancer with bone metastasis: an overview of pain assessment and management. Int J Urol Nurs. 2008;2(3):125–33.

    Article  Google Scholar 

  73. Drudge-Coates L, Rajbabu K. Diagnosis and management of malignant spinal cord compression: part 1. Int J Palliat Nurs. 2008;14(3):110–6.

    PubMed  Google Scholar 

  74. Shaiova L. Difficult pain syndromes: bone pain, visceral pain, and neuropathic pain. Cancer J. 2006;12(5):330–40.

    Article  PubMed  CAS  Google Scholar 

  75. Harris K, Chow E. Need for better documentation and definition of pain flare following external beam radiotherapy in the treatment of bone metastases. J Pain Symptom Manage. 2007;33(1):6–8.

    Article  PubMed  Google Scholar 

  76. Smith MR, Eastham J, Gleason DM, Shasha D, Tchekmedyian S, Zinner N. Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancer. J Urol. 2003;169(6):2008–12.

    Article  PubMed  CAS  Google Scholar 

  77. Saylor PJ, Smith MR. Bone health and prostate cancer. Prostate Cancer Prostatic Dis. 2010;13(1):20–7.

    Article  PubMed  CAS  Google Scholar 

  78. Saad F, Gleason DM, Murray R, Tchekmedyian S, Venner P, Lacombe L, et al. A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma. J Natl Cancer Inst. 2002;94(19):1458–68.

    Article  PubMed  CAS  Google Scholar 

  79. Lee RJ, Saylor PJ, Smith MR. Treatment and prevention of bone complications from prostate cancer. Bone. 2011;48(1):88–95.

    Article  PubMed  CAS  Google Scholar 

  80. Tanvetyanon T, Stiff PJ. Management of the adverse effects associated with intravenous bisphosphonates. Ann Oncol. 2006;17(6):897–907.

    Article  PubMed  CAS  Google Scholar 

  81. Doyle-Lindrud S. Implications of androgen-deprivation therapy in patients with prostate cancer: a case study. Clin J Oncol Nurs. 2006;10(5):565–6.

    Article  PubMed  Google Scholar 

  82. Morris M, Cruickshank S. Bisphosphonate-related osteonecrosis of the jaw in cancer patients: Implications for nurses. Eur J Oncol Nurs. 2010;14(3):205–10.

    Article  PubMed  Google Scholar 

  83. Di Lorenzo G, Buonerba C, Autorino R, De Placido S, Sternberg CN. Castration-resistant prostate cancer: current and emerging treatment strategies. Drugs. 2010;70(8):983–1000.

    Article  PubMed  Google Scholar 

  84. Tannock IF, Osoba D, Stockler MR, Ernst DS, Neville AJ, Moore MJ, et al. Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points. J Clin Oncol. 1996;14(6):1756–64.

    PubMed  CAS  Google Scholar 

  85. Tannock IF, de Wit R, Berry WR, Horti J, Pluzanska A, Chi KN, et al. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med. 2004;351(15):1502–12.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Australian Prostate Cancer Research Center Epworth, Department of Urology, The Royal Melbourne Hospital, Grattan St., Parkville, VIC, 3050, Australia

    Helen Crowe RN, B App Sci, Gdip Epi Biostats, M Nurs Sci

Authors
  1. Helen Crowe RN, B App Sci, Gdip Epi Biostats, M Nurs Sci
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Helen Crowe RN, B App Sci, Gdip Epi Biostats, M Nurs Sci .

Editor information

Editors and Affiliations

  1. New York Presbyterian Hospital, Brady Urologic Health Center, Weill Cornell Medical Center, East 68th Street 525, New York, 10021, New York, USA

    Ashutosh Tewari

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag London

About this chapter

Cite this chapter

Crowe, H. (2013). Nursing Issues in Prostate Cancer. In: Tewari, A. (eds) Prostate Cancer: A Comprehensive Perspective. Springer, London. https://doi.org/10.1007/978-1-4471-2864-9_90

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-2864-9_90

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-2863-2

  • Online ISBN: 978-1-4471-2864-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation